Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 3;1(6):100510.
doi: 10.1016/j.jscai.2022.100510. eCollection 2022 Nov-Dec.

Feasibility and Safety of Intracardiac Echocardiography Use in Transcatheter Left Atrial Appendage Closure Procedures

Affiliations

Feasibility and Safety of Intracardiac Echocardiography Use in Transcatheter Left Atrial Appendage Closure Procedures

Salman Zahid et al. J Soc Cardiovasc Angiogr Interv. .

Abstract

Background: Left atrial appendage closure (LAAC) is usually performed under the guidance of transesophageal echocardiography (TEE). Data on the safety of intracardiac echocardiogram (ICE)-guided LAAC from a real-world population in the United States remain limited. In this study, the aim was to evaluate the trends and outcomes of ICE-guided LAAC procedures using the US National Inpatient Sample.

Methods: This study used the National Inpatient Sample database from quarter 4 of 2015 to 2019. We used a propensity-matched analysis and adjusted odds ratios for in-hospital outcomes/complications. A P value of <.05 was considered significant.

Results: We identified 61,995 weighted LAAC cases. Of these, 1410 patients had ICE-guided LAAC with a lower median age than the patients who had TEE-guided LAAC (75 vs 77 years; P ≤ .01). The use of ICE-guided LAAC increased from 1.7% in 2015 to 2.2% in 2019 (P trend = .75). Major, cardiovascular, neurologic, and pulmonary complications were similar for ICE-guided and TEE-guided LAAC on adjusted analysis. On propensity-matched analysis, the overall vascular complication rates were similar. However, retroperitoneal bleeding remained significantly higher (0.7% vs 0%) with ICE. Gastrointestinal bleeding complications were more frequent in TEE-guided LAAC (3.5% vs 2.1%). The length of stay was similar for both groups (median = 1 day; P = .23); however, ICE was associated with $1769 excess cost of hospitalization ($25,112 vs $23,343; P = .04).

Conclusions: ICE-guided LAAC is safer than TEE-guided LAAC, with similar rates of major complications. However, ICE use was associated with lower rates of gastrointestinal bleeding and higher rates of retroperitoneal bleeding. In addition, ICE-guided LAAC is associated with a similar length of stay but higher costs of hospitalization.

Keywords: echocardiography; intracardiac echocardiography; left atrial appendage closure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow chart. ICD-10, International Classification of Diseases, Tenth Revision; ICE, intracardiac echocardiography; LAAC, left atrial appendage closure; Q4, quarter 4; TEE, transesophageal echocardiography.
Central Illustration
Central Illustration
Safety of ICE in transcatheter LAAC: NIS (2015-2019). ICE, intracardiac echocardiography; LAAC, left atrial appendage closure; NIS, National Inpatient Sample; TEE, transesophageal echocardiography.
Figure 2
Figure 2
Balance of covariates before and after propensity matching. CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; PVD, peripheral vascular disease.
Figure 3
Figure 3
Trend of ICE use for left atrial appendage closure in the US. ICE, intracardiac echocardiography; US, United States.
Figure 4
Figure 4
Adjusted and unadjusted ORs for in-hospital complications. aOR, adjusted odds ratio; ICE, intracardiac echocardiography; uOR, unadjusted odds ratio.
Figure 5
Figure 5
Cost comparison for ICE-guided LAAC. ICE, intracardiac echocardiography; LAAC, left atrial appendage closure; TEE, transesophageal echocardiography.

References

    1. Holmes D.R.J., Kar S., Price M.J., et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12. doi: 10.1016/j.jacc.2014.04.029. - DOI - PubMed
    1. Reddy V.Y., Sievert H., Halperin J., et al. Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA. 2014;312(19):1988–1998. doi: 10.1001/jama.2014.15192. - DOI - PubMed
    1. Holmes D.R.J., Doshi S.K., Kar S., et al. Left Atrial Appendage Closure as an Alternative to warfarin for Stroke Prevention in atrial fibrillation: a Patient-Level Meta-Analysis. J Am Coll Cardiol. 2015;65(24):2614–2623. doi: 10.1016/j.jacc.2015.04.025. - DOI - PubMed
    1. Korsholm K., Jensen J.M., Nielsen-Kudsk J.E. Intracardiac echocardiography from the left atrium for procedural guidance of transcatheter left atrial appendage occlusion. JACC Cardiovasc Interv. 2017;10(21):2198–2206. doi: 10.1016/j.jcin.2017.06.057. - DOI - PubMed
    1. Matsuo Y., Neuzil P., Petru J., et al. Left atrial appendage closure under intracardiac echocardiographic guidance: feasibility and comparison with transesophageal echocardiography. J Am Heart Assoc. 2016;5(10):e003695–e003696. doi: 10.1161/JAHA.116.003695. - DOI - PMC - PubMed

LinkOut - more resources